Long-term all-cause mortality rate after ST-elevation myocardial infarction and its predictors: ST Elevation

Yasaman Shojaei1, Masoumeh Sadeghi2, Kamran Mehrabani3

  • 1Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

Identifying long-term prognostic factors for ST-elevation myocardial infarction (STEMI) is crucial for improving patient survival. Key predictors of mortality include older age, hypertension, lower ejection fraction, and in-hospital complications.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • ST-elevation myocardial infarction (STEMI) poses a significant global health challenge, particularly in low- and middle-income countries.
  • Understanding long-term prognostic factors is essential for enhancing patient outcomes and survival rates.

Purpose of the Study:

  • To identify independent predictors of all-cause mortality in patients following ST-elevation myocardial infarction (STEMI).
  • To provide insights for improved clinical management and follow-up strategies for STEMI survivors.

Main Methods:

  • A 5-year follow-up study of STEMI patients from the SEMI Cohort in Isfahan, Iran.
  • Data collection included demographics, medical history, laboratory results, and in-hospital clinical data.
  • Univariate and multivariate Cox regression models were used to analyze predictors of mortality.

Main Results:

  • Older age, hypertension, lower body mass index, lower initial systolic blood pressure, more affected epicardial territories, and lower ejection fraction were associated with increased mortality.
  • Lower hemoglobin levels, higher plasma glucose, and in-hospital complications significantly predicted higher all-cause mortality.
  • The study analyzed data from 759 STEMI patients, with 158 deaths recorded over the 5-year follow-up period.

Conclusions:

  • Several factors, including demographic, clinical, and in-hospital variables, independently predict long-term mortality after STEMI.
  • These findings are critical for risk stratification and tailoring therapeutic interventions to improve STEMI patient care and survival.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
343
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
736
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
196
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
162
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
199
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
239